Skip to main content

Table 1 Relative frequencies of HBV and HCV related HCC in the world

From: Viral hepatitis and hepatocellular carcinoma

Author [reference]

Country

Era

Sample size

HBsAg + (%)

Anti-HCV + (%)

HBsAg/anti HCV + (%)

Other (%)

Chen, 1990 [74]

Taiwan

NR

66

35 (53.0)

15 (22.7)

7 (10.6)

9 (13.6)

Chuang, 1991 [75]

Taiwan

NR

128

87 (68.0)

13 (10.1)

12 (9.4)

16 (12.5)

Lee, 1992 [76]

Taiwan

NR

326

233 (71.5)

31 (9.5)

10 (3.1)

52 (15.9)

Jeng, 1991 [77]

Taiwan

NR

129

62 (48.1)

29 (22.5)

19 (14.7)

19 (14.7)

Leung, 1992 [78]

Hong Kong

1986–90

424

341 (80.3)

16 (3.8)

15 (4.0)

52 (12.3)

Nishioka, 1990 [79]

Japan

NR

180

64 (35.6)

80 (44.4)

11 (6.1)

25 (13.9)

Saito, 1990 [80]

Japan

NR

253

49 (19.4)

136 (53.8)

2 (0.8)

66 (26.1)

Kiyosawa, 1990 [17]

Japan

1958–89

83

19 (22.9)

51 (61.4)

10 (12.0)

3 (3.6)

Hassan, 2001 [81]

Egypt

1995–96

33

5 (15.2)

25 (75.8)

NR

NR

Kew, 1990 [82]

South Africa

NR

380

137 (36.1)

63 (16.6)

47 (12.4)

127 (33.4)

Yu, 1990 [83]

USA

1984–89

58

22 (37.9)

36 (62.1)

NR

NR

Di Bisceglie, 1991 [84]

USA

1987–88

99

7 (7)

12 (12)

1 (1)

79 (79)

Hadziyannis, 1995 [85]

Greece

1991–92

65

33 (50.8)

5 (7.6)

3 (4.5)

23 (38.3)

Colombo, 1989 [86]

Italy

1975–88

132

19 (14.4)

64 (48.5)

22 (16.7)

27 (20.5)

Levrero, 1991 [87]

Italy

1980–88

167

38 (22.8)

82 (49.1)

15 (9.0)

32 (19.2)

Simonetti, 1992 [88]

Italy

1982–88

212

15 (7.1)

133 (62.7)

18 (8.5)

46 (21.7)

Donato, 1997 [72]

Italy

1995–96

172

37 (21.5)

65 (37.8)

4 (2.3)

66 (38.4)

Stroffolini, 1998 [89]

Italy

1996–97

1083

125 (11.5)

771 (71.2)

55 (5.1)

132 (12.2)

Bruix, 1989 [90]

Spain

NR

96

4 (4.2)

67 (69.8)

5 (5.2)

20 (20.8)

Nalpas, 1991 [91]

France

1982–89

55

3 (5.5)

28 (50.9)

9 (16.3)

15 (27.3)

Van Roey, 2000 [92]

Belgium

90s

154

37 (24.0)

62 (40.0)

NR

55 (36.0)

Haydon, 1997 [93]

UK

1985–94

80

13 (16.3)

22 (27.5)

2 (2.5)

43 (53.8)

  1. NR: not reported; Bold: predominant cause